Addus HomeCare to acquire AccentCare personal care unit for $275m
Addus HomeCare plans to acquire AccentCare's personal care unit for $275 million. The deal puts execution, funding and integration against Addus's existing growth profile, but the unit's financial contribution and closing terms remain unclear.
STOCK PHOTO · MAURÍCIO MASCAROThe story
Addus HomeCare plans to acquire AccentCare's personal care unit for $275 million. Key transaction details including the expected closing date, financing structure and conditions attached to the deal have not been established.
The purchase would add to Addus's personal-care operations. Addus's latest annual figures show $1.4B of revenue in FY 2025, up 23.2% year over year, with a 6.7% net margin and $5.22 diluted EPS; those figures are company-level annual results and do not quantify AccentCare's unit.
For Addus, the concrete link is the purchase price and the operating integration required after closing. For AccentCare, the relevant asset is its personal care unit, though which contracts, employees, markets or liabilities would transfer remains unclear, leaving the revenue and cost bridge unestablished.
The central uncertainty is the limited transaction detail: whether the deal is signed, how Addus would fund it, and what management expects it to contribute remain unknown.
The next evidence points are Addus's transaction announcement or filing, the stated closing conditions and funding terms, and the company's next results update. Those disclosures would determine whether the $275 million purchase adds to growth without weakening Addus's 6.7% net margin.
Our read · Mon, Sep 14
The $275 million AccentCare deal leaves ADUS’s upside tied to acquired growth, while undisclosed funding and unit economics keep execution risk in focus.
Why. The read stays balanced because the purchase price is known but the acquired unit’s revenue, profit contribution and funding are not. Addus’s $1.4B FY 2025 revenue base and 23.2% year-over-year growth provide scale, while its 6.7% net margin leaves the deal’s eventual earnings contribution sensitive to integration and financing terms.
Both cases
What could change this view: The trade is undermined if Addus discloses unfavorable financing, weak unit economics, or integration costs that pressure its 6.7% net margin.
Who reported it · 1
Keep reading
Latest on the Wire
Trump threatens overseas AI data-centre ban for US firmsBitcoin drops below $59,000 as cash rush revives summer-low testGreer says US chip curbs will close China export-control loopholesBlackRock bitcoin ETF posts $541.1 million outflow as tech sell-off spreadsPoland says Russian missiles and drone crashed during Ukraine assaultContinue on the Wire →Latest on the Wire
Anthropic debut fails to halt technology-led slide in US stocksUS MATCH Act puts ASML at center of China chip export disputeBeijing plans to bar young red-chip firms from overseas listingsGerman producer prices jump 8.1% in October as industrial inflation acceleratesContinue on the Wire →Top this week
Nvidia allies lobby board to bring back Jensen Huang as CEONvidia chair rules out Huang return as CEO after 75% sales outlookAnthropic Said to Guide IPO Pricing Above Market RangeNvidia interim CEO Colette Kress faces first earnings test after HuangAnthropic IPO could become the largest in US history on ThursdayAbout this report
Reported by Investing.com, . Who answers for this
The only report in this record. Closes are licensed end-of-day data from Databento; the move after a story is its first close against the close before it. How this is decided →
Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →